Current Advances in the Translation of Vascular Tissue Engineering to the Treatment of Pediatric Congenital Heart Disease

Tissue-engineered vascular grafts (TEVGs) hold great promise for the improvement of outcomes in pediatric patients with congenital cardiac anomalies. Currently used synthetic grafts have several limitations, including thrombogenicity, increased risk of infection, and lack of growth potential. The fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Ethan W., Udelsman, Brooks, Breuer, Christopher K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2012
Materias:
Focus: Biomedical Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375656/
https://www.ncbi.nlm.nih.gov/pubmed/22737051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375656/
https://www.ncbi.nlm.nih.gov/pubmed/22737051

Ejemplares similares